-
2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots
Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety — Despite Significant Number Of Beyaz Adverse Event Reports (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Meeting…
-
Multiple Sclerosis (MS) Medication Gilenya: Timeline Of Actions Taken In US, Canada, And Europe
Increasing Safety Concerns About Novartis Drug Gilenya Are Primarily Cardiovascular Side Effects And Unexplained Death (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2012 Health Canada issued the latest drug safety alert concerning Gilenya…
-
Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL
This Pradaxa MDL Case Will Include Gastrointestinal Bleeding And Other Hemorrhages As Well As Heart Attacks Or Myocardial Infarctions (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa is a blood-thinning drug used to reduce the risk of…
-
Antibiotics Levaquin And Avelox Linked To Increased Risk Of Liver Injury In Older Patients According To New Canadian Study
August 2012 CMAJ Medical Journal Article Adds To Hepatotoxicity Evidence Against These Two Fluoroquinolone Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) According to a case-control study published by the Canadian Medical Association Journal (CMAJ)…
-
New 2012 Medical Study Shows NuvaRing Doubles The Risk Of Stroke And Heart Attack, And The Degree Of Risk Increases With Age
NuvaRing Contraceptive Vaginal Ring Associated With Blood Clots In Arteries That Might Cause Thrombotic Strokes And Myocardial Infarctions (MI) (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: "October 2013 NuvaRing Label Change: Warnings And Precautions…